Company intelligence / Profile preview

Ottr

Ownership: Private
Employees: ~50
Development stage: Other

Overview

Ottr is a specialized healthcare technology company providing transplant patient management software solutions. The company's platform automates clinical workflows for transplant centers, managing patient data from initial referral through long-term post-transplant care. Its solutions are used by major medical centers to maintain regulatory compliance and improve patient outcomes in solid organ and cellular therapy programs. Ottr was acquired by CareDx in 2019, integrating its digital tools into CareDx's broader transplant care portfolio.

Therapeutic areas: HematologyImmunology
Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Ottr.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ottr.

Explore the full profile